US Stock MarketDetailed Quotes

PMVP PMV Pharmaceuticals

Watchlist
  • 1.500
  • 0.0000.00%
Close Dec 20 16:00 ET
  • 1.580
  • +0.080+5.33%
Post 20:01 ET
77.62MMarket Cap-1.50P/E (TTM)

About PMV Pharmaceuticals Company

PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.

Company Profile

SymbolPMVP
Company NamePMV Pharmaceuticals
Listing DateSep 25, 2020
Issue Price18.00
Founded2013
CEOMr. David H. Mack, PhD
MarketNASDAQ
Employees63
Fiscal Year Ends12-31
Address1 Research Way
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540
Phone1-609-642-6670
Websitehttp://www.pmvpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • David H. Mack, PhD
  • President, Chief Executive Officer and Director
  • 2.21M
  • Michael Carulli
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Deepika Jalota, Pharm.D.
  • Chief Development Officer
  • 1.10M
  • Tim Smith
  • Senior Vice President and Head of Corporate Development and Investor Relations
  • --
  • Dr. Marc Fellous, M.D.
  • Senior Vice President and Head of Clinical Development and Medical Affairs
  • --
  • Richard Heyman, PhD
  • Chairman of the Board
  • 176.77K
  • Dr. Arnold J. Levine,PhD
  • Director
  • 220.27K
  • Kirsten Flowers
  • Independent Director
  • 127.77K
  • Dr. Carol G. Gallagher,Pharm.D.
  • Independent Director
  • 124.27K
  • Laurie D. Stelzer, M.B.A.
  • Independent Director
  • 140.27K
  • Dr. Charles M. Baum, M.D.,PhD
  • Independent Director
  • 133.27K
  • Robert Ticktin
  • General Counsel
  • --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List